Research Article

Synthesis and Anti-inflammatory Evaluation of Some New Quinazoline Derivatives

How to cite this article

---

REFERENCES

1. ---

   Huslisson, E.C., 1983. Clinical Pharmacology and Therapeutics Series. Vol. 3, Antirheumatic Drugs Praeger, New York.

2. ---

   El-Kerdawy, M.M., M.B. El-Ashmawy, I.A. Shehata, A.M. Bargash, E.R. El-Bendary and H.A. El-Kashef, 1997. Fused pyrimidines synthesis and anti-inflammatory testing of certain novel imidazo[1,2-c]quinazoline, pyrazolo[3,4-d]triazole[3,4]. Saudi Pharm. J., 5: 46-55.

3. ---

   Gineinah, M.M., M.N. Nasr, A.M. Abdelal, A.A. El-Emam and S.A. Said, 2000. Synthesis and anti-inflammatory evaluation of new 2- and 3- substituted 1,2,4-triazolo[4,3-c] and [1,5-c]quinazoline derivatives. Med. Chem. Res., 10: 243-254.

4. ---

   Inmaculada, R., T. Carmen, U. Amalia, M. Pedro, T. Alberto, G.T. Antonia and M.A. Jose, 2002. A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase. Eur. J. Pharmacol., 434: 177-185.
   CrossRef

5. ---

   Masanori, T., I. Yoshiali, T. Hideyuki, N. Takahiro, T. Hirotada, F. Tominaga and H. Hideya, 2003. Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation. Bioorganic Med. Chem., 11: 383-391.
   Direct Link

6. ---

   Masanori, T., I. Yoshiali, T. Hideyuki, N. Takahiro, T. Hirotada, F. Tominaga and H. Hideya, 2003. Structural activity relationship of 6-fluoroquinazolines: dual acting compounds with inhibitory activities toward both TNF-α production and T cell proliferation. Bioorganic Med. Chem., 11: 609-616.
   CrossRef

7. ---

   Masanori, T., I. Yoshiali, T. Hideyuki, N. Takahiro, T. Hirotada, F. Tominaga and H. Hideya, 2003. A novel structural class of potent inhibitors of NF-κB activation: Structural activity relationship and biological effects of 6-aminoquinazoline derivatives. Bioorganic Med. Chem., 11: 3869-3878.
   Direct Link

8. ---

   Sadanadam, Y.S., K.R.M. Reddy and A.B. Rao, 1987. Synthesis of substituted 2,3-dihydro-1-(β-phenethyl)-2-aryl and 2,3-diaryl-4-(1H)-quinazolines and their pharmacological activities. Eur. J. Med. Chem., 22: 169-173.

9. ---

   Perrin, J.W., W.J. Houlihan and E.I. Takesue, 1984. Anti-inflammatory and other pharmacodynamic properties of five members of the 4-aryl-1-isopropyl-2(1H)-quinazoline series. Arzeneim-Forsch, 34: 879-885.

10. ---

    Chao, Q., L. Deny, H. Shib, L.M. Leoni, D. Genini, D.A. Carson and H.B. Cottam, 2001. Synthesis and pharmacological study of 1-methyl-5-(substituted 3,4-dihydro-4-oxoquinazolin-3-yl)-1H-pyrazole-4-actetates. J. Med. Chem., 36: 737-742.
    CrossRef

11. ---

    Maggio, M.M., G. Daidone, D. Raffa, S. Plesica and V.H.C. Manitone et al., 1999. Substituted isoquinolines and quinazolines as potential antiinflammatory agents. Synthesis and biological evaluation of inhibitors of tumor necrosis factor. J. Med. Chem., 42: 3860-3873.
    CrossRefDirect Link

12. ---

    Mohamed, S.M., K.I. Mohammed, M.A. Ahmed and S.G. Abdel-Hamide, 2004. Quinazoline related derivatives with antimicrobial activities: Part II. J. Biol. Sci., 4: 504-509.
    Direct Link

13. ---

    Winter, C.A., E.A. Risley and G.W. Nuss, 1962. Carrageenin-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs. Exp. Biol. Med., 111: 544-547.
    CrossRefPubMedDirect Link

14. ---

    Mycek, M.J., R.A. Harrey and P.C. Champe, 1987. Pharmacology lippincott's illustrated reviews. 2nd Edn., Chap. 39.

15. ---

    Evans, D. and W.R. Nigel, 1987. Clinical Pharmacology. In: Anti-inflammatory Compounds, Williamson, W.R. (Ed.). 1st Edn., Vol. 9, Chap. 7, Marcel Decker Inc., New York.

Related Articles